CDx approval expands clinical utility of Oncomine Dx Target Test to identify candidates for TIBSOVO

Site in Greenville, N.C., recognized for manufacturing excellence

Accelerated efforts align with the Paris Agreement and Race To Zero to combat climate change

Immune repertoire assays offer high detection rates of malignant clones, empowering researchers to better assess blood cancers